IRS2 and thyroid gland carcinoma: Augenlicht et al. indicated that the tumor suppressor miR-7-5p inhibits thyroid cancer cell proliferation and that its target genes inhibit the EGFR/MAPK and IRS2/PI3K signaling pathways.